Guacetisal
NERVOUS SYSTEM
Also known as: broncaspin, guacetisalum, guaiaspir
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Guacetisal is a drug catalogued in DrugCentral.
- ATC code: N02BA14 (Salicylic acid and derivatives).
- Molecular formula: C16H14O5; molecular weight 286.28 g/mol.
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N02BA14 | NERVOUS SYSTEM › ANALGESICS › OTHER ANALGESICS AND ANTIPYRETICS › Salicylic acid and derivatives |
Chemical structure
| Molecular formula | C16H14O5 |
|---|---|
| Molecular weight | 286.28 g/mol |
| CAS number | 55482-89-8 |
| InChIKey | HSJFYRYGGKLQBT-UHFFFAOYSA-N |
| PubChem CID | 68749 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is the chemical formula of Guacetisal?
Guacetisal has the molecular formula C16H14O5 and a molecular weight of 286.28 g/mol.
Browse: all drugs starting with G · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1333 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2105097 — compound record and bioactivity
- PubChem CID 68749 — chemical identifiers
- DrugBank DB13538 — drug record
- FDA UNII T6EKB9V2O2 — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.